These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial. Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids. Kirsner RS; Heffernan MP; Antaya R Acta Derm Venereol; 2010; 90(1):58-64. PubMed ID: 20107727 [TBL] [Abstract][Full Text] [Related]
11. Influence of pimecrolimus cream 1% on different morphological signs of eczema in infants with atopic dermatitis. Breuer K; Braeutigam M; Kapp A; Werfel T Dermatology; 2004; 209(4):314-20. PubMed ID: 15539895 [TBL] [Abstract][Full Text] [Related]
12. [Letter: Tinea faciei exacerbated by topical immunomodulation: Two case reports]. Ruiz-Villaverde R; Sanchez-Cano D Dermatol Online J; 2010 Mar; 16(3):14. PubMed ID: 20233571 [TBL] [Abstract][Full Text] [Related]
13. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption. Chu CY J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975 [TBL] [Abstract][Full Text] [Related]
14. The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study. Yan AC; Honig PJ; Ming ME; Weber J; Shah KN Arch Dermatol; 2010 Jan; 146(1):57-62. PubMed ID: 20083693 [TBL] [Abstract][Full Text] [Related]
15. Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants. Kaufmann R; Fölster-Holst R; Höger P; Thaçi D; Löffler H; Staab D; Bräutigam M; J Allergy Clin Immunol; 2004 Nov; 114(5):1183-8. PubMed ID: 15536429 [TBL] [Abstract][Full Text] [Related]
16. An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba. Fujita WH; McCormick CL; Parneix-Spake A Int J Dermatol; 2007 Jul; 46(7):700-5. PubMed ID: 17614797 [TBL] [Abstract][Full Text] [Related]
17. Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis. Fleischer AB; Abramovits W; Breneman D; Jaracz E; J Dermatolog Treat; 2007; 18(3):151-7. PubMed ID: 17538803 [TBL] [Abstract][Full Text] [Related]
18. Association between exposure to topical tacrolimus or pimecrolimus and cancers. Hui RL; Lide W; Chan J; Schottinger J; Yoshinaga M; Millares M Ann Pharmacother; 2009 Dec; 43(12):1956-63. PubMed ID: 19903860 [TBL] [Abstract][Full Text] [Related]
19. [A tinea incognito case caused by Trichophyton rubrum with clinical and mycological cure and review of the literature]. Ilkit M; Karakaş M; Yüksel T Mikrobiyol Bul; 2010 Jan; 44(1):149-53. PubMed ID: 20455412 [TBL] [Abstract][Full Text] [Related]
20. An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis. Koc E; Arca E; Kose O; Akar A J Dermatolog Treat; 2009; 20(1):4-9. PubMed ID: 18677657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]